Sensorion SA - ESG Rating & Company Profile powered by AI
Browse to the bottom of this webpage for potential risks for Sensorion SA based on sector, geography and size. This page is a zero-cost ESG report covering Sensorion SA. The report of Sensorion SA incorporates intelligence from across the web and also from public filings by Sensorion SA.
Sensorion SA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.5; made up of an environmental score of 4.0, social score of 5.3 and governance score of 1.1.
3.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1575 | Vitality Biopharma Inc | 3.6 | Medium |
| 1575 | Zhejiang East Asia Pharmaceutical Co Ltd | 3.6 | Medium |
| 1617 | Sensorion SA | 3.5 | Medium |
| 1617 | Anika Therapeutics Inc | 3.5 | Medium |
| 1617 | Aerovate Therapeutics Inc | 3.5 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Sensorion SA have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Sensorion SA disclose current and historical energy intensity?
Sign up for free to unlockDoes Sensorion SA report the average age of the workforce?
Sign up for free to unlockDoes Sensorion SA reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Sensorion SA disclose its ethnicity pay gap?
Sign up for free to unlockDoes Sensorion SA disclose cybersecurity risks?
Sign up for free to unlockDoes Sensorion SA offer flexible work?
Sign up for free to unlockDoes Sensorion SA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Sensorion SA disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Sensorion SA conduct supply chain audits?
Sign up for free to unlockDoes Sensorion SA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Sensorion SA conduct 360 degree staff reviews?
Sign up for free to unlockDoes Sensorion SA disclose the individual responsible for D&I?
Sign up for free to unlockDoes Sensorion SA disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Sensorion SA disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Sensorion SA disclose water use targets?
Sign up for free to unlockDoes Sensorion SA have careers partnerships with academic institutions?
Sign up for free to unlockDid Sensorion SA have a product recall in the last two years?
Sign up for free to unlockDoes Sensorion SA disclose incidents of discrimination?
Sign up for free to unlockDoes Sensorion SA allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Sensorion SA issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Sensorion SA disclose parental leave metrics?
Sign up for free to unlockDoes Sensorion SA disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Sensorion SA disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Sensorion SA disclose the pay ratio of women to men?
Sign up for free to unlockDoes Sensorion SA support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Sensorion SA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Sensorion SA reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Sensorion SA involved in embryonic stem cell research?
Sign up for free to unlockDoes Sensorion SA disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Sensorion SA disclose its waste policy?
Sign up for free to unlockDoes Sensorion SA report according to TCFD requirements?
Sign up for free to unlockDoes Sensorion SA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Sensorion SA disclose energy use targets?
Sign up for free to unlockDoes Sensorion SA disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Sensorion SA have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Sensorion SA
These potential risks are based on the size, segment and geographies of the company.
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.